BioStrand (a subsidiary of IPA)’s Post

Need to improve LLM-generated responses for #drugdiscovery applications? Improve AI's generative capabilities by integrating formal knowledge, ensuring up-to-date and factual information. BioStrand has taken the lead in drug discovery by incorporating Retrieval Augmented Generation (RAG) into its innovative platform. By fusing #LLMs with HYFTs, BioStrand ensures a harmonious blend of generative capabilities and concrete, up-to-date data. This dynamic synergy improves information accuracy and is designed to eliminate the risk of "hallucinated" content.    The result? More informative answers, revolutionizing the landscape of #biotech innovation.   To see this technology in action, schedule a demo today. https://lnkd.in/evpcXkEp #AI #Antibodies #RAG IPA (ImmunoPrecise Antibodies)

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics